X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Molecular Cancer

期刊標題檢索 MOL CANCER 最新評論: How did it go with your friend? (2025-11-04)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Molecular Cancer]您好,您是該頁面的第 410346 位訪客。

期刊簡介
期刊名稱Molecular Cancer Molecular Cancer
LetPub Score
8.5
52 ratings
Rate

Reputation
8.6

Influence
8.3

Speed
8.7

期刊簡稱MOL CANCER
ISSN1476-4598
h-index103
CiteScore
CiteScoreSJRSNIPCiteScore Rank
47.409.2635.233
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Molecular Medicine
Q12 / 177
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Oncology
Q18 / 415
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Cancer Research
Q15 / 233

自引率 (2023-2024)2.20%自引率趨勢
掲載範囲
Molecular Cancer promotes the exchange of ideas, concepts and findings in any area of cancer and related biomedical science, from a molecular point of view. Molecular Cancer is interested in articles from basic, translational and clinical research, opening new avenues for the understanding, prevention, diagnosis and treatment of cancer. Topics of interest include, but are not limited to: cell and tumor biology, angiogenesis, animal models, metastasis, cancer antigens and the immune response to them, cellular signalling and molecular biology, epidemiology, genetic and molecular profiling of cancer and molecular targets, cancer stem cells, DNA damage and repair, cell cycle, apoptosis, molecular virology and vaccine- and antibody-based cancer therapies.
官方網站http://molecular-cancer.biomedcentral.com
在線稿件提交https://submission.nature.com/new-submission/12943/3
開放訪問Yes
出版商BioMed Central
主題領域医学
出版國/地區ENGLAND
發行頻率月刊
創刊年2002
每年文章數218每年文章數趨勢
黃金OA百分比100.00%
OA Related Info
APC: Yes( EUR3990; USD4890; GBP3490; )
APC waiver:Check Notes
Other charges: No
Keywords: oncology、tumour biology、cancer antigens
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
BIOCHEMISTRY & MOLECULAR BIOLOGYSCIEQ14/320
ONCOLOGYSCIEQ19/328
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1476-4598%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 2 Month(s)
競爭力 *來自作者的數據: About 50%
參考鏈接
相關期刊 【Molecular Cancer】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE MEDICINEH-index: 497

    CiteScore: 82.40
    CELLH-index: 705

    CiteScore: 74.80
    Molecular PlantH-index: 85

    CiteScore: 28.20
    NUCLEIC ACIDS RESEARCHH-index: 452

    CiteScore: 31.70
    Molecular CellH-index: 356

    CiteScore: 24.40
    PROGRESS IN LIPID RESEARCHH-index: 132

    CiteScore: 29.90
    TRENDS IN MICROBIOLOGYH-index: 172

    CiteScore: 25.80
    CELL DEATH AND DIFFERENTIATIONH-index: 193

    CiteScore: 29.00
    Nature Chemical BiologyH-index: 182

    CiteScore: 21.50
    TRENDS IN MOLECULAR MEDICINEH-index: 160

    CiteScore: 21.90
    學科內最受檢索的期刊 頁面查看次數
    International Journal of Biological Macromolecules2055743
    CELL BIOCHEMISTRY AND BIOPHYSICS1220562
    FASEB JOURNAL795950
    NUCLEIC ACIDS RESEARCH730074
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS709469
    JOURNAL OF BIOLOGICAL CHEMISTRY404714
    GENETICS AND MOLECULAR RESEARCH345311
    International Journal of Biological Sciences344216
    CELL321114
    ONCOGENE266955
  •  

    Molecular Cancer Molecular Cancer
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    34    35    36    37    38    39    40    下一頁    末頁  (頁
/41)
  [Molecular Cancer] 的評論撰寫評論
作者: Violet Locke


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-04 23:34:55 評論於
Five or six times, lasting for three months
(0) 讚! | Violet Locke

作者: 重阳布衣


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-03 17:01:02 評論於
The magazine editor sent an email asking me to provide the email addresses and names of four potential reviewers. What's going on?
(0) 讚! | 重阳布衣

作者: 白云运良


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-06-26 11:19:54 評論於
Review speed: 1.0 | Submission hit rate: 50.0
Experience sharing: I submitted a manuscript and went through three rounds of editor assign in half a month, and then it went under review. Surprisingly, it was reviewed and completed within another half a month, and the status changed to Reviews Completed. Is this a sign of rejection? I am worried. Can someone with experience explain?
(0) 讚! | 白云运良

作者: 重阳布衣


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-06-19 22:14:16 評論於
May I ask, how many times has the Reviewer Assigned changed, and each time for how long?
(0) 讚! | 重阳布衣

作者: Violet Locke


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-06-14 12:51:10 評論於
What are the chances of being rejected after a major overhaul?
(0) 讚! | Violet Locke

作者: 重阳布衣


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-06-13 20:59:53 評論於
Submitted for 5 days and the status changed to Reviewer Assigned, but no further progress, has anyone encountered this situation before?
(0) 讚! | 重阳布衣

作者: 仲夏凝芙


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-04-20 22:35:37 評論於
The first editor took about a month, the second probably a week, and the third two or three days
(0) 讚! | 仲夏凝芙

作者: 仲夏凝芙


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-04-20 14:46:09 評論於
The review process is a bit slow, probably taking more than two months, but the editors and reviewers are really good
(0) 讚! | 仲夏凝芙

作者: 罗汉沈然


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-04-18 18:06:00 評論於
How long does it take for the editor to be reassigned the first time?
(0) 讚! | 罗汉沈然

作者: 罗汉沈然


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-04-14 14:36:08 評論於
Is this magazine very slow? useful information 2017-03-31 published::Research direction:cancer; immunology; Acceptance rate: about 25% Review time: about 3 months Instant IF=5.87 It is estimated to exceed 6.3 this year
(0) 讚! | 罗汉沈然

作者: 璃月洮洮


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-03-31 19:32:05 評論於
Review speed: 3.0 | Submission acceptance rate: 25.0
Experience sharing: Real-time IF=5.87 It is estimated to exceed 6.3 this year
(0) 讚! | 璃月洮洮

作者: 仲夏凝芙


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-03-12 16:54:09 評論於
I encountered this situation when submitting to another magazine. There are two possibilities, one is that it is truly under external review, and the other is that it is still with the editor
(0) 讚! | 仲夏凝芙

作者: 仲夏凝芙


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-03-12 16:13:09 評論於
No, it is under reviewer
(0) 讚! | 仲夏凝芙

作者: 仲夏凝芙


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-03-12 14:52:59 評論於
Reviewer's comments
Hulu 2017-02-14 Post: If the reviewer is assigned twice before entering the under reviewer, should the comments be submitted?
(0) 讚! | 仲夏凝芙

作者: 仲夏凝芙


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-03-12 09:46:43 評論於
Sorry for the late response as I haven't been here for a long time. I received the revised comments on December 13th. It wasn't until March 11th that I sent the revised version back. It took three months for the revision
(0) 讚! | 仲夏凝芙

作者: 仲夏凝芙


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-03-12 09:46:17 評論於
The article is in the submission process. Can anyone tell me what the status "being processed" means? Has it not been sent for review yet?
(0) 讚! | 仲夏凝芙

作者: Violet Locke


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-02-14 15:19:02 評論於
After the reviewer assigned has changed twice, does the manuscript enter "under reviewer" again or receive review comments? 
张小蹭 2016-12-14 Posted: The time for "editor assigned" has been changed three times, and "reviewer assigned" has been changed twice
(0) 讚! | Violet Locke

作者: Violet Locke


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-02-14 09:32:58 評論於
Reviewer assigned and under reviewer are they the same thing? My article entered reviewer assigned four days after submission and has been stuck here for almost a month, with only one date change in between. Baidu says this means that a reviewer has been invited but has not yet accepted the invitation to review
(0) 讚! | Violet Locke

作者: 刚豪可爱吗


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-01-12 22:00:08 評論於
What is the current status of being processed? Has it not been submitted for review yet?
(0) 讚! | 刚豪可爱吗

作者: 桃花庆波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-12-24 19:17:23 評論於
Have you finished your first trial?
There are still 14 days left, it has been three months since the first trial. Why is it so slow?
(0) 讚! | 桃花庆波

作者: 璃月洮洮


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-12-22 13:18:58 評論於
Review speed: 3.0 | Submission acceptance rate: 25.0 Experience sharing: Immediate IF=5.03 This journal is growing really fast
(0) 讚! | 璃月洮洮

作者: 葵花圣恩


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-12-19 10:15:08 評論於
My current submission status is under review. Does this mean that it has passed the first three assigned editors and is now moving on to external review? Does the under review (or reviewer assigned) status need to change twice to indicate the completion of the external review process?
(0) 讚! | 葵花圣恩

作者: 桃花庆波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-12-19 08:22:39 評論於
How long did it take for your submission to become "under review"?
(0) 讚! | 桃花庆波

作者: 璃月洮洮


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-12-16 09:04:18 評論於
Review speed: 2.0 | Submission acceptance rate: 25.0 Experience sharing: instant IF=4.95 Estimated next year's IF is 6.2
(0) 讚! | 璃月洮洮

作者: 桃花庆波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-12-15 16:51:11 評論於
Okay, now the editor assigned has been changed once, hopefully we can wait for the third time, thank you very much for your reply, may we both have good luck. Zhang Xiaoceng December 14, 2016
(0) 讚! | 桃花庆波

首頁    上一頁    34    35    36    37    38    39    40    下一頁    末頁  (頁
/41)

開始撰寫 [Molecular Cancer] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*